GNRSU Stock Crashes 99.99% on Pink Sheets, Greenrose Holdings Faces Delisting

GNRSU stock has collapsed to near-zero levels, trading at just $0.000001 USD on the OTC Pink Sheets market. The Greenrose Holding Company Inc., a New York-based cannabis cultivator and processor, has experienced a devastating 99.99% decline from its previous close of $0.15. This catastrophic drop reflects severe financial distress and liquidity concerns for the healthcare sector company. With a market cap of just $13 USD and only 145 shares trading daily, GNRSU stock represents one of the market’s most distressed securities. Investors should understand the critical risks before considering any position in this penny stock.

GNRSU Stock Price Collapse and Market Data

The Greenrose Holding Company Inc. stock has reached critical lows that signal extreme financial distress. Trading on the OTC Pink Sheets exchange under ticker GNRSU, the stock now trades at $0.000001 per share, down from $0.15 just one trading session ago.

This represents a staggering 99.99933% single-day loss. The year-to-date decline stands at 99.99977%, while the one-year loss reaches 99.99995%. Volume remains microscopic at just 145 shares traded, indicating virtually no market liquidity. The 50-day and 200-day moving averages both sit at $0.15, showing the stock’s recent catastrophic departure from historical trading levels. With a market capitalization of only $13 USD and 12.85 million shares outstanding, GNRSU has become essentially worthless in market terms.

Financial Metrics and Valuation Breakdown

Despite the stock’s near-zero price, GNRSU’s financial metrics reveal a company with some operational activity but severe balance sheet problems. The company reports an EPS of $3.097 and a PE ratio of 0.00000032, which are mathematically extreme due to the microscopic stock price.

Key financial indicators show concerning liquidity: the current ratio stands at just 0.21, meaning current liabilities far exceed current assets. Working capital is deeply negative at -$103.4 million, while tangible asset value is -$116.3 million. The debt-to-equity ratio of 1.57 indicates heavy leverage. However, the company maintains a gross profit margin of 59% and operating margin of 39%, suggesting some underlying business profitability. Revenue per share reaches $1.58, but this cannot offset the massive balance sheet deterioration and liquidity crisis threatening the company’s survival.

Cannabis Industry Operations and Business Model

The Greenrose Holding Company Inc. operates as a specialty cannabis cultivator and processor based in Amityville, New York. Founded in 2014, the company employs 910 full-time workers and focuses on producing medical cannabis and derivative products through cultivation, processing, and packaging operations.

The company’s healthcare sector classification reflects its position in the drug manufacturing industry. However, regulatory challenges, market saturation in state-level cannabis markets, and potential federal policy shifts have created headwinds for the entire sector. Track GNRSU on Meyka for real-time updates on this distressed security. With CEO Nicole Conboy leading operations, the company faces an uphill battle to restore shareholder value and prevent complete equity wipeout. The combination of operational challenges and severe financial distress has created a perfect storm for this once-promising cannabis producer.

Market Sentiment and Trading Activity

Trading Activity: GNRSU exhibits virtually no market activity, with only 145 shares changing hands daily. This microscopic volume indicates complete loss of investor confidence and market abandonment. The stock trades on the OTC Pink Sheets, the lowest tier of US equity markets, where transparency and regulatory oversight are minimal. No bid-ask spreads exist in any meaningful sense at these price levels.

Liquidation Concerns: The company faces potential delisting from all major exchanges and possible bankruptcy proceedings. Negative working capital of -$103.4 million and negative tangible asset value suggest the company may lack sufficient assets to cover liabilities. Shareholders face near-total loss of investment, with equity likely to be wiped out in any restructuring or liquidation scenario. The combination of zero trading volume, negative equity metrics, and operational distress creates an extremely high-risk environment for any remaining investors.

Final Thoughts

GNRSU stock trades at $0.000001, indicating severe market rejection of Greenrose Holding Company Inc. The company faces critical liquidity crisis with negative working capital of $103.4 million and minimal trading volume. Despite maintaining a 59% gross margin, operational profitability cannot offset catastrophic balance sheet deterioration. Meyka AI assigns a B grade, though this does not reflect extreme distress in current pricing. GNRSU represents a highly speculative, distressed situation with extreme bankruptcy risk. Any investment should be considered a total loss scenario.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.